KRAWS LIKES GILEAD, ISIS AND INTREXON ON PHARMA SIDE ANCHOR OFF-CAMERA ENGLISH SAYING: So let's name some names. There are a couple of very small companies that you like. Small in terms of- they're not heavily priced if you will. Sure. $5 or lower, let's go with some of those. JEFF KRAWS, CEO, CRYSTAL RESEARCH (ENGLISH) SAYING: Sure, we'll go with some of those. In the bigger area, we still like Gilead and Isis and Intrexon of course. Even with some of those stocks making new highs, they're just phenomenal companies with great management, great R&D.; And I think they're going to be hugely successful, and likely one of the large cap pharma is going to come and buy them at some point. I believe that. But going to the smaller ones, when you look at companies like- we'll start off with Unilife. Unilife is a medical device company if you will. It does injectable drugs. It's coming up with a new novel, innovative syringe to prevent needle stick injuries. They've also come up with a drug delivery technology to help patients who have trouble swallowing pills. So here's a company- the whole platform of ways to get drugs into the body in a safer, more efficient manner, it's a stock that's $3 in change, it's a company that has tremendous patent portfolio, it's a company that very likely one of the large needle companies that are backed in there and someone's probably going to end up going out to buy. So there's one example of a small company that's really came out of nowhere. It came out of Australia actually and it has now become a significant player in that area. ANCHOR OFF-CAMERA ENGLISH SAYING: Another one is MetaStat. JEFF KRAWS, CEO, CRYSTAL RESEARCH (ENGLISH) SAYING: MetaStat is a great company. MetaStat is a company that is really approaching oncology. You think about the largest killers out there, oncology comes up in the top category, certainly in the top few of both for men and women. And it's still an area where outside of paclitaxel or Taxol or some of the oncology products- some of which have huge toxicity issues. ...

• published: 14 Aug 2013
• views: 8